Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guilingji Capsule for Mild-to-Moderate Cognitive Impairment
NCT03647384Phase 2Unknown
- Sponsor
- Xiyuan Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2019
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of Guilingji in Mild Cognitive Impairment (MCI), sponsored by Xiyuan Hospital. Status: unknown.
02
Drugs
Guilingji
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT03647384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03647384.